Cargando…
SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149174/ https://www.ncbi.nlm.nih.gov/pubmed/34048723 http://dx.doi.org/10.1016/S2468-1253(21)00184-9 |
_version_ | 1783697907208159232 |
---|---|
author | Alexander, James L Powell, Nick |
author_facet | Alexander, James L Powell, Nick |
author_sort | Alexander, James L |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8149174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81491742021-05-26 SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? Alexander, James L Powell, Nick Lancet Gastroenterol Hepatol Correspondence Elsevier Ltd. 2021-07 2021-05-26 /pmc/articles/PMC8149174/ /pubmed/34048723 http://dx.doi.org/10.1016/S2468-1253(21)00184-9 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Alexander, James L Powell, Nick SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? |
title | SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? |
title_full | SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? |
title_fullStr | SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? |
title_full_unstemmed | SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? |
title_short | SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? |
title_sort | sars-cov-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change? |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149174/ https://www.ncbi.nlm.nih.gov/pubmed/34048723 http://dx.doi.org/10.1016/S2468-1253(21)00184-9 |
work_keys_str_mv | AT alexanderjamesl sarscov2vaccinationinimmunosuppressedpatientswithinflammatoryboweldiseaseshouldourapproachchange AT powellnick sarscov2vaccinationinimmunosuppressedpatientswithinflammatoryboweldiseaseshouldourapproachchange AT sarscov2vaccinationinimmunosuppressedpatientswithinflammatoryboweldiseaseshouldourapproachchange |